Alexander Kilbanov

Title: Alexander Kilbanov: Innovator in Abuse-Deterrent Drug Formulations

Introduction

Alexander Kilbanov is a notable inventor based in Boston, MA, recognized for his contributions to the field of pharmaceuticals. He has developed innovative solutions aimed at addressing the critical issue of drug abuse, particularly concerning opioids. His work has significant implications for public health and safety.

Latest Patents

Kilbanov holds a patent for an abuse-deterrent pharmaceutical composition designed to minimize the risk of improper drug administration. This formulation modifies the drug's lipophilicity by creating a salt with one or more fatty acids, enhancing its resistance to misuse. The composition is engineered to prevent the immediate release of a substantial portion of the drug, even if the formulation is physically compromised. When used as directed, the drug is released slowly, ensuring its therapeutic effects while reducing the potential for abuse.

Career Highlights

Kilbanov is currently associated with Collegium Pharmaceutical, Inc., where he continues to advance his research and development efforts. His innovative approach to drug formulation has positioned him as a key player in the pharmaceutical industry, particularly in the realm of abuse-deterrent technologies.

Collaborations

Kilbanov has collaborated with esteemed colleagues such as Jane C. Hirsh and Alison B. Fleming. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Alexander Kilbanov's work in developing abuse-deterrent drug formulations represents a significant advancement in the fight against drug abuse. His innovative contributions are vital for improving patient safety and addressing public health challenges.